Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of neurologic sequelae in patients with post-acute sequelae of SARS-CoV-2 infection (PASC)
- PMID: 36989078
- DOI: 10.1002/pmrj.12976
Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of neurologic sequelae in patients with post-acute sequelae of SARS-CoV-2 infection (PASC)
References
REFERENCES
-
- Bull-Otterson L, Baca S, Saydah S, et al. Post-COVID conditions among adult COVID-19 survivors aged 18-64 and ≥ 65 years-United States, march 2020-November 2021. MMWR Morb Mortal Wkly Rep. 2022;71:713-717. doi:10.15585/mmwr.mm7121e1externalicon
-
- Liotta EM, Batra A, Clark JR, et al. Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol. 2020;7(11):2221-2230. doi:10.1002/I3.51210
-
- Graham EL, Clark JR, Orban ZS, et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 “long haulers”. Ann Clin Transl Neurol. 2021;8:1073-1085. doi:10.1002/acn3.51350
-
- Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med. 2022;28:2406-2415. doi:10.1038/s41591-022-02001-z
-
- Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet. Psychiatry. 2021;8(5):416-427. doi:10.1016/S2215-0366(21)00084-5
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
